1. Congiu, Chiara, Minelli, Alessandra, Bonvicini, Cristian, Segala, Matilde, Gennarelli, Massimo. 2014. The role of the potassium channel gene KCNK2 in major depressive disorder. In Psychiatry research, 225, 489-92. doi:10.1016/j.psychres.2014.11.061. https://pubmed.ncbi.nlm.nih.gov/25535009/
2. Wang, Jing, Li, Jiaqiong, Cheng, Dan, Li, Xiang, Dong, Zigang. 2023. miR-132-3p promotes heat stimulation-induced esophageal squamous cell carcinoma tumorigenesis by targeting KCNK2. In Molecular carcinogenesis, 62, 583-597. doi:10.1002/mc.23504. https://pubmed.ncbi.nlm.nih.gov/37014157/
3. Liou, Ying-Jay, Chen, Tai-Jui, Tsai, Shih-Jen, Cheng, Chih-Ya, Hong, Chen-Jee. . Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment. In Pharmacogenetics and genomics, 19, 735-41. doi:10.1097/FPC.0b013e32832cbe61. https://pubmed.ncbi.nlm.nih.gov/19741570/
4. Le Guen, Yann, Philippe, Cathy, Riviere, Denis, Mangin, Jean-François, Frouin, Vincent. 2018. eQTL of KCNK2 regionally influences the brain sulcal widening: evidence from 15,597 UK Biobank participants with neuroimaging data. In Brain structure & function, 224, 847-857. doi:10.1007/s00429-018-1808-9. https://pubmed.ncbi.nlm.nih.gov/30519892/
5. Lin, Xu, Wu, Jing-Fang, Wang, Dong-Mei, Zhang, Wen-Jing, Xue, Gang. 2020. The correlation and role analysis of KCNK2/4/5/15 in Human Papillary Thyroid Carcinoma microenvironment. In Journal of Cancer, 11, 5162-5176. doi:10.7150/jca.45604. https://pubmed.ncbi.nlm.nih.gov/32742463/
6. Sullivan, Kyle A, Vitko, Iuliia, Blair, Kathryn, Kapur, Jaideep, Perez-Reyes, Edward. 2023. Drug-Inducible Gene Therapy Effectively Reduces Spontaneous Seizures in Kindled Rats but Creates Off-Target Side Effects in Inhibitory Neurons. In International journal of molecular sciences, 24, . doi:10.3390/ijms241411347. https://pubmed.ncbi.nlm.nih.gov/37511107/